By ETF Desk
Manipal Health Enterprises Limited (MHEL) is set to debut on Indian stock exchanges with an initial public offering (IPO) on 10 September 2024. The shares will be priced within a band of ₹2,800-₹3,000 per share, with a gross market price (GMP) of ₹2,950. This pricing reflects the company’s robust financials and growth prospects in the healthcare sector.
Founded in 2018, MHEL operates a network of tertiary and specialty hospitals across Karnataka, with a focus on advanced diagnostics, treatment facilities, and telemedicine services. The company, a subsidiary of the Manipal Group, has reported consistent revenue growth, driven by its expanding patient base and adoption of digital health solutions.
The IPO will offer 5 crore new shares, with a total subscription demand of approximately 18.5 crore, indicating a strong investor appetite for the company’s business model and market position.
The proceeds from the IPO will be utilised to fund the construction of new hospital wings, enhance digital infrastructure, and support research and development initiatives in medical technologies. In addition, the capital infusion will help strengthen the company’s balance sheet and facilitate strategic acquisitions within the healthcare sector. Source: Google News – Manipal.